Skip to main content

Advertisement

Table 2 Cohort results for 2014 of camp and non-camp Syrian refugee culture-confirmed patients who started anti-TB treatment 9 months prior

From: “Impact of and response to increased tuberculosis prevalence among Syrian refugees compared with Jordanian tuberculosis prevalence: case study of a tuberculosis public health strategy”

Tuberculosis cohort findings* by quarter, 2014 1st quarter % (n/N) 2nd quarter % (n/N) 3rd quarter % (n/N)
Cure/completion rate (without MDR†) 91 % (21/23) 96 % (23/24) 85 % (17/20)
Likely to complete treatment (without MDR) 91 % (21/23) 100 % (24/24) 95 % (19/20)
Death rate 0 % (0/0) 0 % (0/0) 5 % (1/20)
Default treatment rate 9 % (2/23) 0 % (0/0) 0 % (0/0)
Fail treatment rate 0 % (0/0) 0 % (0/0) 0 % (0/0)
  1. *Source definitions: CDC. Understanding the TB cohort review process: instruction guide, 2006. [http://www.cdc.gov/tb/publications/guidestoolkits/cohort/method.htm]
  2. †MDR, multiple-drug resistant